Target intelligence / Profile preview

RAN pseudogene 2 (RANP2)

Target
RANP2
Molecular classification
Other (pseudogene)
01

Overview

RAN pseudogene 2 (RANP2) is a noncoding genomic element derived from the RAN gene, a critical GTPase involved in nucleocytoplasmic transport, mitosis, and cell cycle regulation[3]. Unlike its parent gene, RANP2 is classified as a pseudogene and does not encode a functional protein, nor is it considered a therapeutic target or molecular receptor[1][5]. Recent studies suggest that some pseudogenes may be transcribed and play regulatory roles—such as acting as competing endogenous RNAs by sequestering microRNAs—but specific biological functions or disease associations for RANP2 have not been annotated[1][4][5]. RANP2 is primarily referenced in genomic databases and bioinformatic analyses as a pseudogene, lacking direct involvement in disease, drug interaction, or molecular signaling pathways[1][5]. RANP2 is a pseudogene, not a receptor, enzyme, transporter, or transcription factor[1][5]. Its functional annotation is largely absent, and it is not considered a druggable or clinical target. Querying for classic target information (drugs, biomarkers, pathways) returns null results due to its pseudogene status. If you are seeking information regarding the protein-coding RAN gene (ras-related nuclear protein), see associated entries for RAN—not RANP2—for molecular targeting or disease relevance[3].

Other names
RANP2RAN pseudogene 2
02

Biological functions

Other (pseudogenes often function via regulation or as decoys for microRNAs, but direct functional roles for RANP2 are not annotated)
03

Disease associations

Other (No direct disease roles for RANP2 as a pseudogene; however, parent gene RAN is implicated in cancer and neurological disorders, but these do not directly extend to RANP2)

Beyond the preview

Go deeper on RAN pseudogene 2 (RANP2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RAN pseudogene 2 (RANP2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call